Press Releases Medicover AB

Equities

MCOV B

SE0009778848

Healthcare Facilities & Services

Market Closed - Nasdaq Stockholm Other stock markets 10:30:00 10/03/2026 pm IST			5-day change	1st Jan Change
209.00 ^SEK	+0.48%		0.00%	-5.22%

09/03	Lancelot Sverige dipped 1.4 percent in February – lagged behind strong large-cap market	FW
13/02	PriorNilsson Evolve Down 4.85 Percent in January - Adds Medicover to Portfolio	FW

Press Releases

10/02	Medicover : Interim Report January December 2025	PU
09/02	Medicover announces new financial targets - continued organic growth and margin expansion	AQ
22/01	Invitation to Medicover’s results presentation for Q4 2025	AQ
07/01	Invitation to Medicover's Investor Update 2026	AQ
28/11	Number of shares and votes in Medicover	AQ
05/11	Medicover : Interim report July-September 2025	PU
22/25/22	Medicover : Additional interim results strengthen the clinical evidence of Medicover Genetics' MRD assay in non-small cell lung cancer	PU
22/25/22	Additional interim results strengthen the clinical evidence of Medicover Genetics’ MRD assay in non-small cell lung cancer	AQ
21/25/21	Medicover : Invitation to Medicover's results presentation for Q3 2025	PU
21/25/21	Invitation to Medicover’s results presentation for Q3 2025	AQ
03/25/03	Medicover : nomination committee for the AGM 2026	PU
03/25/03	Medicover’s nomination committee for the AGM 2026	AQ
19/25/19	Medicover : climate targets validated by the Science Based Targets initiative (SBTi)	PU
19/25/19	Medicover’s climate targets validated by the Science Based Targets initiative (SBTi)	AQ
27/25/27	Medicover updates its Social Finance Framework	AQ
24/25/24	Medicover : Interim Report April-June 2025	PU
09/25/09	Medicover : Invitation to Medicover's results presentation for Q2 2025	PU
09/25/09	Invitation to Medicover’s results presentation for Q2 2025	AQ
30/25/30	Number of shares and votes in Medicover	AQ
18/25/18	Lukasz Krause new Chief Digital Information Officer (CDIO) Medicover	AQ
02/25/02	Medicover : INITIAL RESULTS FROM THE DART STUDY INDICATE THAT MEDICOVER GENETICS' MRD TEST CAN DETECT MINIMAL RESIDUAL DISEASE IN LUNG CANCER PATIENTS	PU
02/25/02	INITIAL RESULTS FROM THE DART STUDY INDICATE THAT MEDICOVER GENETICS’ MRD TEST CAN DETECT MINIMAL RESIDUAL DISEASE IN LUNG CANCER PATIENTS	AQ
29/25/29	Bulletin from annual general meeting in Medicover AB (publ)	AQ
16/25/16	Medicover : Invitation to Medicover's results presentation for Q1 2025	PU
16/25/16	Invitation to Medicover’s results presentation for Q1 2025	AQ